InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
TLR4-based adjuvant - MPLA-SM VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
R848 VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
Pam3CSK4 VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
Poly(I:C) (HMW) VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
ODN 2088 control | Depletion of Toll-Like Receptor-9 Attenuates Renal Tubulointerstitial Fibrosi... | 2021 | Front. Cell Dev. Biol. | Zheng H. et al. | DOI: 10.3389/fcell.2021.641527 |
ODN 2088 | Depletion of Toll-Like Receptor-9 Attenuates Renal Tubulointerstitial Fibrosi... | 2021 | Front. Cell Dev. Biol. | Zheng H. et al. | DOI: 10.3389/fcell.2021.641527 |
Primocin® | PINK1-mediated inhibition of EGFR dimerization and activation impedes EGFR-dr... | 2021 | Cancer Res. | Lin E.P.Y. et al. | DOI: 10.1158/0008-5472.CAN-20-2582 |
Normocure™ - Antimicrobial Reagent | Establishing Human Intestinal Enteroid/Organoid Lines from Preterm Infant and... | 2020 | Methods Mol Biol. | Stewart C.J. et al. | DOI: 10.1007/978-1-0716-0338-3_16 |
Pan-Caspase inhibitor - Z-VAD-FMK | Apoptotic effects of dehydrocrenatidine via JNK and ERK pathway regulation in... | 2021 | Biomed Pharmacother. | Ho H.Y. et al. | DOI: 10.1016/j.biopha.2021.111362 |
Normocure™ - Antimicrobial Reagent | A non-invasive method to generate induced pluripotent stem cells from primate... | 2021 | Sci Rep. | Geuder J. et al. | DOI: 10.1038/s41598-021-82883-0 |
Mouse TLR4 Reporter HEK293 Cells (NF-κB) | Smectite promotes probiotic biofilm formation in the gut for cancer immunothe... | 2021 | Cell Rep. | Han C. et al. | DOI: 10.1016/j.celrep.2021.108706 |
Mouse TLR2 Reporter HEK293 Cells (NF-κB) | Smectite promotes probiotic biofilm formation in the gut for cancer immunothe... | 2021 | Cell Rep. | Han C. et al. | DOI: 10.1016/j.celrep.2021.108706 |
QUANTI-Blue™ | Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 inf... | 2021 | Retrovirology | Cingöz O. et al. | DOI: 10.1186/s12977-021-00548-2 |
THP1-Lucia™ ISG Cells | Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 inf... | 2021 | Retrovirology | Cingöz O. et al. | DOI: 10.1186/s12977-021-00548-2 |
QUANTI-Luc™: Luciferase Detection Reagent | Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 inf... | 2021 | Retrovirology | Cingöz O. et al. | DOI: 10.1186/s12977-021-00548-2 |
IFN-α/β Reporter HEK 293 Cells | Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 inf... | 2021 | Retrovirology | Cingöz O. et al. | DOI: 10.1186/s12977-021-00548-2 |
Ramos-Blue™ Cells | Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic ... | 2021 | Mol. Ther. | Ylösmäki E. et al. | DOI: 10.1016/j.omto.2021.02.006 |
Recombinant human CD40L | Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic ... | 2021 | Mol. Ther. | Ylösmäki E. et al. | DOI: 10.1016/j.omto.2021.02.006 |
Zeocin® | Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic ... | 2021 | Mol. Ther. | Ylösmäki E. et al. | DOI: 10.1016/j.omto.2021.02.006 |
LumiKine™ Xpress hIFN-β 2.0 | Human SLC15A4 is crucial for TLR-mediated type I Interferon production and mi... | 2021 | Int Immunol. | Kobayashi T. et al. | DOI: 10.1093/intimm/dxab006 |